Patiromer to Reduce Albuminuria Through Increased Renin Angiotensin Aldosterone System Inhibition in Patients With CKD-A Feasibility Trial

Patiromer to Reduce Albuminuria Through Increased Renin Angiotensin Aldosterone System Inhibition in Patients With CKD-A Feasibility Trial

Introduction: We tested the feasibility of adding a potassium binder to enable increased renin angiotensin aldosterone system inhibition (RAASi) and reduce albuminuria in patients with chronic kidney disease (CKD). In a controlled trial design, a potassium binder was introduced exclusively in patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Frederik H. Mårup, Christian D. Peters, Steffen F. Nielsen, Louis Nygaard, Bo Madsen, Frank H. Mose, Henrik Birn
Format: Article
Language:English
Published: Elsevier 2024-08-01
Series:Kidney International Reports
Subjects:
albuminuria
CKD
hyperkalemia
patiromer
RAASi
renin angiotensin aldosterone system
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924017133
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2468024924017133

Similar Items